Elevance Health Q3 2026 revenue up 0.7%
Elevance Health reported Q3 2026 earnings ahead of expectations, raising full-year diluted EPS guidance to at least $22.00. The results reflect improved operating performance and a net non-operating benefit of $1.85 per share.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed